Lorcaserin Extended-Release Tablets and Novoeight recombinant
Determining the interaction of Lorcaserin Extended-Release Tablets and Novoeight recombinant and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Novolin 70/30
- Lorcaserin Extended-Release Tablets-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Lorcaserin Extended-Release Tablets-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Lorcaserin Extended-Release Tablets-Novolin N
- Lorcaserin Extended-Release Tablets-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))
- Lorcaserin Extended-Release Tablets-Novolin N (Insulin NPH (Vials))
- Novoeight recombinant-Lorcaserin Hydrochloride
- Novoeight recombinant-Lorcaserin Tablets
- Novoeight recombinant-Lorcet
- Novoeight recombinant-Lorcet Plus
- Novoeight recombinant-Lorcet Tablets
- Novoeight recombinant-Lorlatinib